As an American researcher, Dr. Judy A. Mikovits is a vaccine and medical industry activist. As research director of the Whittemore Peterson Institute (WPI) in Reno, Nevada; on November 18, 2011 Mikovits was arrested for not handing over her research to her employer (WPI) regarding a controversial publication to the journal Science. Having been investigated for allegedly manipulating data, Mikovits had lead a research effort that reported in 2009 that a retrovirus known as xenotropic murine leukemia virus-related virus (XMRV) was associated with CFS and may have had a causal role. This research came under fire and lead the journal to make a retraction on December 22, 2011. Arrested in her Ventura, CA home, charges against her were later dismissed by the District Attorney's office - Reno, NV.
Mikovits has a PhD in biochemistry and molecular biology from George Washington University (1992). Her doctorate thesis defense entitles "Negative Regulation of HIV Expression in Monocytes", changed the paradigm for therapeutic treatment of HIV. This won her the graduate student of the year award in 1991. Her studies are accredited to saving millions of lives infected with HIV/AIDS.
In 2006 Dr Mikovits became attracted to the plight of families with neuroimmune diseases including ME/CFS and Autism and was primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation and these diseases.
Apart from a 20 year career with the National Cancer Institute in Frederick, Maryland, and leading various pharmaceutical studies, in 2012 it was learned that XMRV was a contaminant of the Silverman lab and the XMRV's isolated were a new human exogenous and transmissible retrovirus family, which are strong associated with neuroimmune disease and cancer.
Judy has co-authored more than 50 peer reviewed publications and book chapters. She is also co-author of the book Plague.
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fansYes, let's begin connecting
Find new listeners
Understand your audience
Engage your fanbase